Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|September 16, 2021
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosisAdrià Juanola, Isabel Graupera, Chiara Elia, et al.Gastroenterology|September 17, 2020
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and PrognosisCristina Solé, Susie Guilly, Kevin Da Silva, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2023
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular ProfilingJordi Gratacós-Ginès, Emma Avitabile, Carla Montironi, et al.Hepatology (Baltimore, Md.)|February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective StudyPatricia Huelin, Elsa Solà, Chiara Elia, et al.Journal of Nursing Management|May 9, 2020
Acuity, nurse staffing and workforce, missed care and patient outcomes: A cluster-unit-level descriptive comparisonMaria-Eulàlia Juvé-Udina, Maribel González-Samartino, Maria Magdalena López-Jiménez, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2018
High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based StudyLlorenç Caballería, Guillem Pera, Ingrid Arteaga, et al.Journal of Hepatology|August 31, 2019
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and AsiaMiquel Serra-Burriel, Isabel Graupera, Pere Torán, et al.Plos One|September 19, 2018
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based studyNúria Fabrellas, Rosario Hernández, Isabel Graupera, et al.Journal of Hepatology|July 17, 2016
Plasma copeptin as biomarker of disease progression and prognosis in cirrhosisElsa Solà, Annarein J C Kerbert, Hein W Verspaget, et al.Journal of Hepatology|August 24, 2018
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trialElsa Solà, Cristina Solé, Macarena Simón-Talero, et al.Pageof 9